Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01ISE
|
|||
| Former ID |
DIB002069
|
|||
| Drug Name |
Bimakalim
|
|||
| Synonyms |
EMD-52692; SR-44866
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Angina pectoris [ICD-11: BA40; ICD-9: 413] | Phase 2 | [1] | |
| Company |
Merck KGaA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H14N2O2
|
|||
| Canonical SMILES |
CC1(C=C(C2=C(O1)C=CC(=C2)C#N)N3C=CC=CC3=O)C
|
|||
| InChI |
1S/C17H14N2O2/c1-17(2)10-14(19-8-4-3-5-16(19)20)13-9-12(11-18)6-7-15(13)21-17/h3-10H,1-2H3
|
|||
| InChIKey |
JTVSKASWNROQQF-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 117545-11-6
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Potassium channel unspecific (KC) | Target Info | Agonist | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Lack of anti-ischemic efficacy of the potassium channel opener bimakalim in patients with stable angina pectoris. Cardiovasc Drugs Ther. 2004 Jan;18(1):37-46. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.